SIKLOS PAEDIATRIC 50mg dispersible tablets
SIK-FR-24-1
Phase 2 small_molecule active
Quick answer
SIKLOS PAEDIATRIC 50mg dispersible tablets for Sickle Cell Disease is a Phase 2 program (small_molecule) at THERAVIA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- THERAVIA
- Indication
- Sickle Cell Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active